The Long, Winding Road of Immunotherapy Research
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Tag: Leukemia
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
At the end of last week, the U.S. Food and Drug Administration (FDA) announced the approval of the first...
A young adult shares his story of leaving college and learning to rely on his mother as he battled...
Last week, the U.S. Food and Drug Administration (FDA) added another therapeutic to the armamentarium for hematologist-oncologists when it...
Check out the 10 blog posts from 2014 that attracted the most attention. They cover a lot of ground,...
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
The summer issue of Cancer Today is out and features stories on the challenge of having both cancer and...